Company: EDSA
Filing Date: 2025-04-04
Form Type: DEF 14A
Source: 0001171843-25-002028
Chunk: 4

Company: Edesa Biotech, Inc.
Filing Date: 2025-04-04
Form: DEF 14A
Chunk 4
---
 and                                                                                                                                                                                                                                             |
| 5. | such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.                                                                                                                                                                                                                                                                    |

What are the Board’s recommendations?

Our Board recommends that you vote:

| ● | FOR the election of each of the seven director nominees; |

| ● | FOR the advisory vote to approve the compensation of our named executive officers as described in this proxy statement; |

| ● | FOR the approval of an amendment to the 2019 Plan to (i) increase the number of shares available for issuance under the 2019 Plan by 1,725,000 shares, (ii) remove the 2019 Plan’s “fungible share pool” provisions and (iii) increase the number of shares issuable under the 2019 Plan as incentive stock options from 171,429 to 300,000; |

With respect to any other matter that properly comes before our Annual Meeting, the proxy holders will vote as recommended by the Board or, if no recommendation is given, at their own discretion.

Who is entitled to vote at the meeting?

Only shareholders of record at the close of business on the record date, March 31, 2025 (the “Record Date”), are entitled to receive notice of the Annual Meeting and to vote the shares of that they held on that date at the Annual Meeting, or any postponement or adjournment of the Annual Meeting. Holders of record of common shares have the right to vote on all matters brought before the Annual Meeting.

Holders of our common shares are entitled to one vote per share on each matter to be voted upon. As of the Record Date, we had 7,022,678 common shares outstanding.

Who can attend the meeting?

Only shareholders as of the Record Date, or their duly appointed proxies, may attend the Annual Meeting. Please note that if you hold your shares in “street name” (that is, through a broker or other nominee), you will need to bring a copy of your proxy card delivered to you by your broker or a legal proxy given to you by your broker and check in at the registration desk at the meeting.

<div align='center'>2</div>

What constitutes a quorum?

Our Amended and Restated Articles (the “Articles”) require the representation of at least one person who is, or who represents by proxy, one or more shareholders who, in the aggregate, hold at least thirty-three and one-third percent (33-1/3%) of the